Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Genelux Corp (NASDAQ: GNLX) closed the day trading at $5.3 down -32.40% from the previous closing price of $7.84. In other words, the price has decreased by -$32.40 from its previous closing price. On the day, 1.56 million shares were traded. GNLX stock price reached its highest trading level at $7.502 during the session, while it also had its lowest trading level at $4.3444.
Ratios:
For a better understanding of GNLX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.20 and its Current Ratio is at 4.20. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Lake Street on October 21, 2025, initiated with a Buy rating and assigned the stock a target price of $16.
On October 29, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $8.
On August 28, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $10.ROTH MKM initiated its Buy rating on August 28, 2024, with a $10 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 12 ’25 when Ryder Sean sold 4,475 shares for $2.92 per share. The transaction valued at 13,067 led to the insider holds 47,621 shares of the business.
Zindrick Thomas sold 10,764 shares of GNLX for $31,431 on May 12 ’25. The President and CEO now owns 191,447 shares after completing the transaction at $2.92 per share. On May 12 ’25, another insider, Yu Yong, who serves as the VP, Clinical Trial Operations of the company, sold 5,579 shares for $2.92 each. As a result, the insider received 16,291 and left with 47,640 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GNLX now has a Market Capitalization of 201674400 and an Enterprise Value of 266480464.
Stock Price History:
The Beta on a monthly basis for GNLX is -0.04, which has changed by 1.6757679 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, GNLX has reached a high of $8.53, while it has fallen to a 52-week low of $1.99. The 50-Day Moving Average of the stock is 3.15%, while the 200-Day Moving Average is calculated to be 41.13%.
Shares Statistics:
Over the past 3-months, GNLX traded about 169.84K shares per day on average, while over the past 10 days, GNLX traded about 304860 shares per day. A total of 37.61M shares are outstanding, with a floating share count of 32.34M. Insiders hold about 14.40% of the company’s shares, while institutions hold 19.84% stake in the company. Shares short for GNLX as of 1760486400 were 2212278 with a Short Ratio of 13.03, compared to 1757894400 on 2167209. Therefore, it implies a Short% of Shares Outstanding of 2212278 and a Short% of Float of 5.9799999999999995.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 5.0 analysts currently analyzing and rating the stock of Genelux Corp (GNLX).The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.2 and low estimates of -$0.31.
Analysts are recommending an EPS of between -$0.82 and -$0.97 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is -$0.96, with 5.0 analysts recommending between -$0.87 and -$1.02.
